REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Medizen Humancare Inc Co. Ltd. (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Medizen Humancare Inc Co. Ltd. Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a Korea-based company mainly engaged in the provision of disease prediction services. The Company is involved in the provision of disease prediction services named My-Genome Check (M-CHECK). In addition, it is involved in the conduction of research projects, as well as the manufacturing and sale of saliva kits. The Company was founded on July 20, 2012.
and its shares are listed on KOREA NEW EXCHANGE(KONEX) on January 26, 2016.

Headquarters
20F Keungil Tower 223, Teheran-Ro, Gangnam-Gu, Seoul, Republic Of Korea
Seoul; Seoul;

Contact Details: Purchase the Medizen Humancare Inc Co. Ltd. report to view the information.

Website: http://www.medizencare.com

Basic Information
Total Employees:
Purchase the Medizen Humancare Inc Co. Ltd. report to view the information.
Outstanding Shares:
Purchase the Medizen Humancare Inc Co. Ltd. report to view the information.
Financial Auditors:
Purchase the Medizen Humancare Inc Co. Ltd. report to view the information.
Incorporation Date:
2012
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Subsidiaries
Medizen Humancre Hk Limited
Company Performance
Financial values in the chart are available after Medizen Humancare Inc Co. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
15.83%▲
Total operating revenue
39.37%▲
Operating profit (EBIT)
34.72%▲
EBITDA
90.3%▲
Net Profit (Loss) for the Period
34.62%▲
Total assets
-19.59%▼
Total equity
-19.6%▼
Operating Profit Margin (ROS)
30.2%▲
Net Profit Margin
30.79%▲
Return on Equity (ROE)
-14.72%▼
Debt to Equity Ratio
9.84%▲
Quick Ratio
0.22%▲
Cash Ratio
0.06%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo